Jean‐paul Ortonne

Jean‐paul Ortonne's AcademicInfluence.com Rankings

Jean‐paul Ortonne

Medical

#1652

World Rank

#2015

Historical Rank

Dermatology

#24

World Rank

#35

Historical Rank

medical Degrees

Jean‐paul Ortonne

Philosophy

#5006

World Rank

#7705

Historical Rank

Logic

#2356

World Rank

#3333

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Jean‐paul Ortonne's Degrees

Doctorate Dermatology Côte d'Azur University

Why Is Jean‐paul Ortonne Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Jean‐paul Ortonne's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial (2005) (1002)
Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis. (2012) (905)
Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION) (2007) (679)
European S3‐Guidelines on the systemic treatment of psoriasis vulgaris (2009) (668)
Microphthalmia Gene Product as a Signal Transducer in cAMP-Induced Differentiation of Melanocytes (1998) (461)
Sox9 Is Essential for Outer Root Sheath Differentiation and the Formation of the Hair Stem Cell Compartment (2005) (413)
Integrin β4 mutations associated with junctional epidermolysis bullosa with pyloric atresia (1995) (394)
An international, randomized, double-blind, placebo-controlled phase 3 trial of intramuscular alefacept in patients with chronic plaque psoriasis. (2003) (361)
Ras mediates the cAMP‐dependent activation of extracellular signal‐regulated kinases (ERKs) in melanocytes (2000) (336)
Herlitz's junctional epidermolysis bullosa is linked to mutations in the gene (LAMC2) for the γ2 subunit of nicein/kalinin (LAMININ–5) (1994) (332)
Different cis-Acting Elements Are Involved in the Regulation of TRP1 and TRP2 Promoter Activities by Cyclic AMP: Pivotal Role of M Boxes (GTCATGTGCT) and of Microphthalmia (1998) (306)
A classification of psoriasis vulgaris according to phenotype (2007) (278)
Nitric oxide produced by ultraviolet-irradiated keratinocytes stimulates melanogenesis. (1997) (277)
Secukinumab induction and maintenance therapy in moderate‐to‐severe plaque psoriasis: a randomized, double‐blind, placebo‐controlled, phase II regimen‐finding study (2012) (261)
What are melanocytes really doing all day long…? (2009) (259)
Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug. (2002) (253)
Defective expression of plectin/HD1 in epidermolysis bullosa simplex with muscular dystrophy. (1996) (235)
Inhibition of the Phosphatidylinositol 3-Kinase/p70S6-Kinase Pathway Induces B16 Melanoma Cell Differentiation* (1996) (226)
Comparison of two etanercept regimens for treatment of psoriasis and psoriatic arthritis: PRESTA randomised double blind multicentre trial (2010) (224)
Biological therapies in the systemic management of psoriasis: International Consensus Conference (2004) (214)
Photoprotective properties of skin melanin (2002) (209)
Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: Systematic review and meta-analysis. (2015) (208)
Rab27a: A key to melanosome transport in human melanocytes. (2001) (205)
Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else? (2008) (200)
Inhibition of the Mitogen-activated Protein Kinase Pathway Triggers B16 Melanoma Cell Differentiation* (1998) (190)
A 52-week trial comparing briakinumab with methotrexate in patients with psoriasis. (2011) (189)
Roaccutane treatment guidelines: results of an international survey. (1997) (184)
Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo. (2004) (182)
Monoclonal antibody GB3, a new probe for the study of human basement membranes and hemidesmosomes. (1987) (181)
A homozygous nonsense mutation in the alpha 3 chain gene of laminin 5 (LAMA3) in lethal (Herlitz) junctional epidermolysis bullosa. (1995) (181)
Imiquimod 5% cream for the treatment of actinic keratosis: results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology. (2004) (179)
Efficacy and safety of infliximab vs. methotrexate in patients with moderate‐to‐severe plaque psoriasis: results of an open‐label, active‐controlled, randomized trial (RESTORE1) (2011) (171)
Regulation of the Microphthalmia-associated Transcription Factor Gene by the Waardenburg Syndrome Type 4 Gene,SOX10 * (2000) (171)
Comparative study of calcipotriol (MC 903) ointment and betamethasone 17-valerate ointment in patients with psoriasis vulgaris. (1992) (167)
Monoclonal antibody GB3 defines a widespread defect of several basement membranes and a keratinocyte dysfunction in patients with lethal junctional epidermolysis bullosa. (1991) (159)
Impact of adalimumab treatment on health‐related quality of life and other patient‐reported outcomes: results from a 16‐week randomized controlled trial in patients with moderate to severe plaque psoriasis (2007) (157)
A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris. (2002) (157)
Regulation of tyrosinase gene expression by cAMP in B16 melanoma cells involves two CATGTG motifs surrounding the TATA box: implication of the microphthalmia gene product (1996) (151)
Prebiotics and synbiotics: two promising approaches for the treatment of atopic dermatitis in children above 2 years (2006) (150)
Reconstituted Skin from Murine Embryonic Stem Cells (2003) (150)
Successful treatment of moderate to severe plaque psoriasis with the PEGylated Fab′ certolizumab pegol: results of a phase II randomized, placebo‐controlled trial with a re‐treatment extension (2012) (142)
Physiopathology and genetics of vitiligo. (2005) (140)
Treatment of chronic erosive oral lichen planus with low concentrations of topical tacrolimus: an open prospective study. (2002) (135)
Involvement of Microphthalmia in the Inhibition of Melanocyte Lineage Differentiation and of Melanogenesis by Agouti Signal Protein* (1998) (130)
Evaluation of cutaneous photodamage using a photographic scale (1994) (130)
Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate‐to‐severe psoriasis: a randomized controlled trial (2006) (126)
Oral alitretinoin (9-cis-retinoic acid) therapy for chronic hand dermatitis in patients refractory to standard therapy: results of a randomized, double-blind, placebo-controlled, multicenter trial. (2004) (125)
The Short Arm of the Laminin γ2 Chain Plays a Pivotal Role in the Incorporation of Laminin 5 into the Extracellular Matrix and in Cell Adhesion (2001) (123)
Latest insights into skin hyperpigmentation. (2008) (122)
Vitiligo and Other Hypomelanoses of Hair and Skin (1983) (120)
Transposable B2 SINE elements can provide mobile RNA polymerase II promoters (2001) (118)
Anatomic distribution of melanocytes in normal nail unit: an immunohistochemical investigation. (1997) (114)
In vivo reflectance confocal microscopy detects pigmentary changes in melasma at a cellular level resolution (2009) (114)
PUVA-induced repigmentation of vitiligo: scanning electron microscopy of hair follicles. (1980) (113)
Adalimumab for moderate to severe chronic plaque psoriasis: efficacy and safety of retreatment and disease recurrence following withdrawal from therapy (2011) (113)
A phase IIIb, multicentre, randomized, double‐blind, vehicle‐controlled study of the efficacy and safety of adalimumab with and without calcipotriol/betamethasone topical treatment in patients with moderate to severe psoriasis: the BELIEVE study (2010) (108)
IGF1 promotes resistance to apoptosis in melanoma cells through an increased expression of BCL2, BCL-X(L), and survivin. (2008) (107)
PUVA‐induced repigmentation of vitiligo: a histochemical (split‐DOPA) and ultrastructural study (1979) (107)
Therapeutical approaches in melasma. (2007) (107)
Cloning of the laminin alpha 3 chain gene (LAMA3) and identification of a homozygous deletion in a patient with Herlitz junctional epidermolysis bullosa. (1995) (107)
GB3 MONOCLONAL ANTIBODY FOR DIAGNOSIS OF JUNCTIONAL EPIDERMOLYSIS BULLOSA (1986) (106)
Cloning and Complete Primary Structure of the Mouse Laminin α3 Chain (1995) (104)
Chronic urticaria: an internet survey of health behaviours, symptom patterns and treatment needs in European adult patients (2009) (103)
Efficacy of once‐daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris (2004) (102)
Microphthalmia-associated transcription factor (MITF) is required but is not sufficient to induce the expression of melanogenic genes. (2003) (102)
A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trial. (2008) (100)
Transcriptional profiling shows altered expression of wnt pathway- and lipid metabolism-related genes as well as melanogenesis-related genes in melasma. (2011) (100)
Anatomical mapping of Merkel cells in normal human adult epidermis (1991) (99)
The new basement membrane antigen recognized by the monoclonal antibody GB3 is a large size glycoprotein: modulation of its expression by retinoic acid. (1988) (99)
[Genetics of vitiligo]. (1995) (96)
Long-term control of atopic dermatitis with pimecrolimus cream 1% in infants and young children: a two-year study. (2005) (95)
Improvements in patient‐reported outcomes in moderate‐to‐severe psoriasis patients receiving continuous or paused etanercept treatment over 54 weeks: the CRYSTEL study (2009) (95)
Management of field change in actinic keratosis (2007) (93)
Genetic correction of canine dystrophic epidermolysis bullosa mediated by retroviral vectors. (2003) (92)
Corrective gene transfer of keratinocytes from patients with junctional epidermolysis bullosa restores assembly of hemidesmosomes in reconstructed epithelia (1998) (92)
PI3K mediates protection against TRAIL-induced apoptosis in primary human melanocytes (2004) (92)
Tazarotene cream for the treatment of facial photodamage: a multicenter, investigator-masked, randomized, vehicle-controlled, parallel comparison of 0.01%, 0.025%, 0.05%, and 0.1% tazarotene creams with 0.05% tretinoin emollient cream applied once daily for 24 weeks. (2001) (88)
Melasma treatment with pulsed-dye laser and triple combination cream: a prospective, randomized, single-blind, split-face study. (2011) (87)
Hair melanins and hair color: ultrastructural and biochemical aspects. (1993) (87)
Melanin pigmentary disorders: treatment update. (2005) (86)
Microphthalmia associated transcription factor is a target of the phosphatidylinositol-3-kinase pathway. (2003) (85)
A 24‐week randomized clinical trial investigating the efficacy and safety of two doses of etanercept in nail psoriasis (2013) (85)
Abnormal binding of an anti‐amnion antibody to epidermal basement membrane provides a novel diagnostic probe for junctional epidermolysis bullosa (1985) (84)
Animal models for skin blistering conditions: absence of laminin 5 causes hereditary junctional mechanobullous disease in the Belgian horse. (2002) (83)
The Pigmentary System: Physiology and Pathophysiology: Second Edition (2007) (83)
Long-term treatment of atopic dermatitis with pimecrolimus cream 1% in infants does not interfere with the development of protective antibodies after vaccination. (2005) (83)
Etanercept monotherapy in patients with psoriasis: a summary of safety, based on an integrated multistudy database. (2006) (82)
Retinoid therapy of pigmentary disorders (2006) (82)
Treatment of oral erosive lichen planus with 1% pimecrolimus cream: a double-blind, randomized, prospective trial with measurement of pimecrolimus levels in the blood. (2007) (82)
The treatment of 45 patients with cutaneous T‐cell lymphoma with low doses of interferon‐α2a and etretinate (1991) (82)
Guidelines for clinical trials in melasma (2006) (82)
The efficacy of afamelanotide and narrowband UV-B phototherapy for repigmentation of vitiligo. (2013) (80)
Effect of a preceding laser dermabrasion on the outcome of combined therapy with narrowband ultraviolet B and potent topical steroids for treating nonsegmental vitiligo in resistant localizations (2012) (80)
Follicular mycosis fungoides. A clinical and histologic variant of cutaneous T-cell lymphoma: report of two cases. (1993) (78)
Kalinin is abnormally expressed in epithelial basement membranes of Herlitz's junctional epidermolysis bullosa patients (1992) (77)
308‐nm excimer lamp vs. 308‐nm excimer laser for treating vitiligo: a randomized study (2010) (76)
Spleen tyrosine kinase functions as a tumor suppressor in melanoma cells by inducing senescence-like growth arrest. (2009) (74)
HGF induces fibronectin matrix synthesis in melanoma cells through MAP kinase-dependent signaling pathway and induction of Egr-1 (2005) (74)
Clinical evidence of benefits of a dietary supplement containing probiotic and carotenoids on ultraviolet‐induced skin damage (2010) (73)
Production of basement membrane components by a reconstructed epidermis cultured in the absence of serum and dermal factors (1993) (73)
Oral photochemotherapy in the treatment of lichen planus (LP) (1978) (72)
Pathophysiology of vitiligo. (1997) (72)
Long-term safety and efficacy of etanercept in patients with psoriasis: an open-label study. (2010) (72)
SPARC functions as an anti-stress factor by inactivating p53 through Akt-mediated MDM2 phosphorylation to promote melanoma cell survival (2011) (71)
What should be considered in treatment of melasma. (2010) (70)
αMSH and Cyclic AMP Elevating Agents Control Melanosome pH through a Protein Kinase A-independent Mechanism (2009) (70)
Tumor necrosis factor alpha-mediated inhibition of melanogenesis is dependent on nuclear factor kappa B activation (1999) (69)
Normal and psoriatic human skin grafts on "nude" mice: morphological and immunochemical studies. (1981) (68)
A controlled study of the activity of hyaluronic acid in the treatment of venous leg ulcers (1996) (67)
Dynamic characterization of the molecular events during in vitro epidermal wound healing. (2002) (67)
308-nm excimer laser therapy in alopecia areata. (2004) (66)
Patients with moderate‐to‐severe psoriasis recapture clinical response during re‐treatment with etanercept (2009) (66)
Pigmentary changes in aged and photoaged skin. (1997) (66)
How to prescribe antihistamines for chronic idiopathic urticaria: desloratadine daily vs PRN and quality of life (2009) (65)
Comparative study of ketoconazole 2% foaming gel and betamethasone dipropionate 0.05% lotion in the treatment of seborrhoeic dermatitis in adults. (1992) (65)
Identification of a lethal form of epidermolysis bullosa simplex associated with a homozygous genetic mutation in plectin. (2003) (65)
Alefacept-induced decreases in circulating blood lymphocyte counts correlate with clinical response in patients with chronic plaque psoriasis. (2003) (64)
Role of thiol compounds in mammalian melanin pigmentation. II. Glutathione and related enzymatic activities. (1982) (64)
The cleavage of microphthalmia-associated transcription factor, MITF, by caspases plays an essential role in melanocyte and melanoma cell apoptosis. (2005) (64)
Efficacy of Treatment with Calcipotriol/Betamethasone Dipropionate Followed by Calcipotriol Alone Compared with Tacalcitol for the Treatment of Psoriasis vulgaris: A Randomised, Double-Blind Trial (2004) (64)
SDZ ASM 981 is the first non-steroid that suppresses established nickel contact dermatitis elicited by allergen challenge. (2000) (63)
Role of thiol compounds in mammalian melanin pigmentation: Part I. Reduced and oxidized glutathione. (1981) (63)
Impact of efalizumab on patient-reported outcomes in high-need psoriasis patients: results of the international, randomized, placebo-controlled Phase III Clinical Experience Acquired with Raptiva (CLEAR) trial [NCT00256139] (2005) (63)
Defective barrier function in melasma skin (2011) (62)
Characterization of the Molecular Defects in Rab27a, Caused by RAB27A Missense Mutations Found in Patients with Griscelli Syndrome* (2003) (61)
Normal Merkel cells express a synaptophysin-like immunoreactivity. (1988) (61)
Famciclovir vs. aciclovir in immunocompetent patients with recurrent genital herpes infections: a parallel‐groups, randomized, double‐blind clinical trial (2001) (61)
Use of the 308-nm excimer laser for psoriasis and vitiligo. (2006) (61)
Divided nevus of the penis: an unusual location. (1998) (60)
A study of nineteen immunocompromised patients with extensive skin lesions caused by Pseudomonas aeruginosa with and without bacteremia. (1991) (60)
Skin and Nail Responses after 1 Year of Infliximab Therapy in Patients with Moderate-to-Severe Psoriasis: A Retrospective Analysis of the EXPRESS Trial (2010) (59)
Reflectance confocal microscopy for pigmentary disorders (2010) (58)
In vitro and in vivo anti-melanoma effects of ciglitazone. (2009) (57)
Lichen planus: study with anti‐human T lymphocyte antigen (anti‐HTLA) serum on frozen tissue sections (1978) (56)
Oral isotretinoin treatment policy. Do we all agree? (1997) (56)
Splicing modulation of integrin beta4 pre-mRNA carrying a branch point mutation underlies epidermolysis bullosa with pyloric atresia undergoing spontaneous amelioration with ageing. (1999) (56)
Juvenile psoriasis and its clinical management: a European expert group consensus (2010) (55)
Calcitriol shows greater persistence of treatment effect than betamethasone dipropionate in topical psoriasis therapy (2003) (55)
Herlitz junctional epidermolysis bullosa keratinocytes display heterogeneous defects of nicein/kalinin gene expression. (1994) (55)
Rapid prenatal diagnosis of epidermolysis bullosa letalis using GB3 monoclonal antibody (1987) (54)
Occurrence and properties of tyrosinase in the ejected ink of cephalopods (1981) (53)
In B16 melanoma cells, the inhibition of melanogenesis by TPA results from PKC activation and diminution of microphthalmia binding to the M-box of the tyrosinase promoter (1998) (53)
The Onychomatricoma: Additional Histologic Criteria and Immunohistochemical Study (2002) (52)
Why statistics matter: limited inter-rater agreement prevents using the psoriasis area and severity index as a unique determinant of therapeutic decision in psoriasis. (2012) (51)
Efficacy and safety of continuous versus paused etanercept treatment in patients with moderate-to-severe psoriasis over 54 weeks: the CRYSTEL study (2008) (51)
Oral pimecrolimus in the treatment of moderate to severe chronic plaque‐type psoriasis: a double‐blind, multicentre, randomized, dose‐finding trial (2005) (51)
A phase II dose‐ranging study of topical resiquimod to treat actinic keratosis (2008) (51)
Aetiology and pathogenesis of psoriasis (1996) (51)
Clinical response to alefacept: results of a phase 3 study of intramuscular administration of alefacept in patients with chronic plaque psoriasis (2003) (50)
Efficacy and safety of adalimumab in patients with psoriasis previously treated with anti‐tumour necrosis factor agents: subanalysis of BELIEVE (2011) (49)
Tumor-derived fibronectin is involved in melanoma cell invasion and regulated by V600E B-Raf signaling pathway. (2007) (49)
Pyemotes ventricosus Dermatitis, Southeastern France (2008) (48)
Aeromonas hydrophila with Plasmid-Borne Class A Extended-Spectrum β-Lactamase TEM-24 and Three Chromosomal Class B, C, and D β-Lactamases, Isolated from a Patient with Necrotizing Fasciitis (2004) (47)
Pseudomonas aeruginosa O-11 folliculitis. Development into ecthyma gangrenosum in immunosuppressed patients. (1985) (47)
Fexofenadine hydrochloride in the treatment of chronic idiopathic urticaria: A placebo-controlled, parallel-group, dose-ranging study (1998) (47)
Characterization of nail matrix melanocytes with anti-PEP1, anti-PEP8, TMH-1, and HMB-45 antibodies. (1994) (47)
Murine Laminin α3A and α3B Isoform Chains Are Generated by Usage of Two Promoters and Alternative Splicing* (1997) (47)
A homozygous in-frame deletion in the collagenous domain of bullous pemphigoid antigen BP180 (type XVII collagen) causes generalized atrophic benign epidermolysis bullosa. (1997) (46)
Inherited junctional epidermolysis bullosa in the German Pointer: establishment of a large animal model. (2005) (45)
Visceral artery aneurysms in Von Recklinghausen's neurofibromatosis. (1997) (45)
Cyclic AMP promotes a peripheral distribution of melanosomes and stimulates melanophilin/Slac2‐a and actin association (2004) (45)
Insulin binding properties of normal and transformed human epidermal cultured keratinocytes. (1985) (45)
Three Activator Protein-1-binding Sites Bound by the Fra-2·JunD Complex Cooperate for the Regulation of Murine Laminin α3A (lama3A) Promoter Activity by Transforming Growth Factor-β* (1998) (45)
Psoralen therapy in vitiligo. (1989) (45)
Patient Satisfaction with Psoriasis Therapies: An Update and Introduction to Biologic Therapy (2004) (43)
Herpes gestationis factor reacts with the amniotic epithelial basement membrane (1987) (43)
The Role of Topical Retinoids in the Treatment of Pigmentary Disorders (2009) (42)
Superiority of tacrolimus 0·1% ointment compared with fluticasone 0·005% in adults with moderate to severe atopic dermatitis of the face: results from a randomized, double‐blind trial (2009) (42)
The majority of epidermal Merkel cells are non-proliferative: a quantitative immunofluorescence analysis. (1987) (40)
Effect of pimecrolimus cream 1% on the long‐term course of pediatric atopic dermatitis (2004) (40)
Acral hyperpigmented macules and longitudinal melanonychia in AIDS patients (1992) (39)
Ehlers-Danlos syndrome with subependymal periventricular heterotopias (1996) (39)
Activation of the unfolded protein response in vitiligo: the missing link? (2012) (39)
Importance of treatment of skin xerosis in diabetes (2011) (39)
Lack of efficacy of tacrolimus in the treatment of vitiligo in the absence of UV-B exposure. (2006) (39)
Recommendations for the Long-Term Treatment of Psoriasis with Infliximab: A Dermatology Expert Group Consensus (2008) (39)
Piebaldism, Waardenburg's syndrome, and related disorders. "Neural crest depigmentation syndromes"? (1988) (38)
Predominance of the recurrent mutation R635X in the LAMB3 gene in European patients with Herlitz junctional epidermolysis bullosa has implications for mutation detection strategy. (1997) (38)
Ciglitazone negatively regulates CXCL1 signaling through MITF to suppress melanoma growth (2011) (38)
The new 940-nanometer diode laser: an effective treatment for leg venulectasia. (2003) (38)
Genetic bases of severe junctional epidermolysis bullosa presenting spontaneous amelioration with aging. (2001) (38)
Cross-talk between RhoGTPases and stress activated kinases for matrix metalloproteinase-9 induction in response to keratinocytes injury. (2003) (38)
Nicein (BM-600) in junctional epidermolysis bullosa: polyclonal antibodies provide new clues for pathogenic role. (1993) (38)
Cost-Effectiveness of Once-Daily Treatment with Calcipotriol/Betamethasone Dipropionate Followed by Calcipotriol Alone Compared with Tacalcitol in the Treatment of Psoriasis vulgaris (2005) (38)
Expression of the chemokine receptor CCR5 in psoriasis and results of a randomized placebo controlled trial with a CCR5 inhibitor (2007) (37)
Guidelines for clinical trials in melasma. Pigmentation Disorders Academy. (2006) (37)
Imatinib mesilate (Glivec®): a systemic depigmenting agent for extensive vitiligo? (2005) (37)
[Prevalence of hepatitis C virus in oral erosive lichen]. (1998) (37)
Genetic disorders of pigmentation. (2005) (36)
Identification of a 37 kilodalton protein at the epidermal basement membrane by an antiserum to human amnion. (1986) (36)
Involvement of the Digestive Tract in Cowden's Disease (1980) (36)
Efficacy of the 308-nm excimer laser in the treatment of mycosis fungoides. (2004) (36)
The p53/p21Cip1/ Waf1 pathway mediates the effects of SPARC on melanoma cell cycle progression (2011) (35)
Efficacy and Safety of Desloratadine in Adults with Chronic Idiopathic Urticaria (2007) (35)
Idiopathic guttate hypomelanosis. Ultrastructural study. (1980) (35)
Pseudo‐dermatomyositis induced by long‐term hydroxyurea therapy: report of two cases (1996) (34)
Mechanisms That Cause Abnormal Skin Color (2007) (34)
Diagnosis and treatment monitoring of toenail onychomycosis by reflectance confocal microscopy: prospective cohort study in 58 patients. (2014) (34)
The effects of ultraviolet exposure on skin melanin pigmentation. (1990) (34)
Cloning and complete primary structure of the mouse laminin alpha 3 chain. Distinct expression pattern of the laminin alpha 3A and alpha 3B chain isoforms. (1995) (34)
Chronic urticaria: diagnostic recommendations (2000) (33)
Merkel cells express desmosomal proteins and cytokeratins. (1985) (33)
The genes for nicein/kalinin 125- and 100-kDa subunits, candidates for junctional epidermolysis bullosa, map to chromosomes 1q32 and 1q25-q31. (1994) (33)
Isolated Deficient α6β4 Integrin Expression in the Gut Associated with Intractable Diarrhea (1999) (32)
A novel homozygous nonsense mutation in the LAMC2 gene in patients with the Herlitz junctional epidermolysis bullosa. (1994) (32)
Hemidesmosome assembly assessed by expression of a wild-type integrin beta 4 cDNA in junctional epidermolysis bullosa keratinocytes. (1997) (32)
Efficacious and safe management of moderate to severe scalp seborrhoeic dermatitis using clobetasol propionate shampoo 0·05% combined with ketoconazole shampoo 2%: a randomized, controlled study (2011) (32)
Surgical management of vitiligo (2006) (32)
Long-term treatment with 0.1% tacrolimus ointment in adults with atopic dermatitis: results of a two-year, multicentre, non-comparative study. (2007) (32)
Altered tissue expression pattern of cell adhesion molecules, ICAM‐1, E‐selectin and VCAM‐1, in bullous pemphigoid during methotrexate therapy (2004) (32)
Successful treatment of crusted (Norwegian) scabies with ivermectin in two patients with human immunodeficiency virus infection (1996) (31)
Thalidomide‐induced amenorrhoea: two cases (2001) (31)
Establishment and characterization of cell line LSV5 that retains the altered adhesive properties of human junctional epidermolysis bullosa keratinocytes. (1996) (31)
Retinoic acid and pigment cells: a review of in‐vitro and in‐vivo studies (1992) (30)
Solar ultraviolet light activates extracellular signal-regulated kinases and the ternary complex factor in human normal keratinocytes (1998) (30)
The Normal Color of Human Skin (2007) (30)
Comment on Elejalde syndrome and relationship with Griscelli syndrome (2003) (30)
Surgical management of vitiligo and other leukodermas: evidence-based practice guidelines (2007) (29)
Wnt inhibitory factor (WIF)‐1 promotes melanogenesis in normal human melanocytes (2014) (29)
Binding specificity of guinea pig anti-alpha-keratin polypeptide sera on human keratinocytes: comparison of their receptors with those of human epidermal cytoplasmic antibodies. (1980) (29)
Immunohistochemical analysis of the skin in junctional epidermolysis bullosa using laminin 5 chain specific antibodies is of limited value in predicting the underlying gene mutation (1997) (29)
Hair melanin and hair color. (1997) (28)
0.3% Tacrolimus gel and 0.5% Tacrolimus cream show efficacy in mild to moderate plaque psoriasis: Results of a randomized, open-label, observer-blinded study. (2006) (28)
Pulsed dye laser-mediated photodynamic therapy for acne inversa is not successful: A pilot study on four cases (2009) (28)
Binding of USF to a non-canonical E-box following stress results in a cell-specific derepression of the lama3 gene. (2002) (28)
Adult Still's disease associated with hepatitis C virus infection. (1994) (27)
[Diagnostic value of café-au-lait spots (author's transl)]. (1980) (27)
5-Methoxypsoralen increases the plasma melatonin levels in humans. (1987) (27)
[The 308 nm excimer laser in dermatology]. (2005) (27)
Porphyria cutanea tarda, C282Y, H63D and S65C HFE Gene Mutations and Hepatitis C Infection: A Study from Southern France (2003) (27)
Peripherin, a neuronal intermediate protein, is stably expressed by neuroendocrine carcinomas of the skin, their xenograft on nude mice, and the corresponding primary cultures. (1993) (27)
Detection of Novel LAMC2 Mutations in Herlitz Junctional Epidermolysis Bullosa (1997) (26)
Escherichia coli cellulitis: two cases. (1992) (26)
Urticaria and its subtypes: the role of second-generation antihistamines. (2012) (26)
Efficacy, Safety and Tolerability of an Optimized Avulsion Technique with Onyster® (40% Urea Ointment with Plastic Dressing) Ointment Compared to Bifonazole-Urea Ointment for Removal of the Clinically Infected Nail in Toenail Onychomycosis: a Randomized Evaluator-Blinded Controlled Study (2013) (25)
Ecthyma Gangrenosum Caused by Klebsiella pneumoniae (1995) (25)
Fibroblastic rheumatism: clinical, histological, immunohistological, ultrastructural and biochemical study of a case (1993) (25)
Diving suit dermatitis caused by Pseudomonas aeruginosa: two cases. (1994) (24)
[Halo eczema around a histiocytofibroma: the Meyerson phenomenon]. (1993) (24)
Chloroquine-induced hypopigmentation of hair and freckles. Association with congenital renal failure. (1985) (24)
Reduced Expression of the Epithelial Adhesion Ligand Laminin 5 in the Skin Causes Intradermal Tissue Separation* (2001) (24)
Porphyria cutanea tarda in association with human immunodeficiency virus infection: it is related to hepatitis C virus infection? (1994) (24)
Evolution of nevi during treatment with natalizumab: A prospective follow-up of patients treated with natalizumab for multiple sclerosis. (2010) (23)
Hyaluronate in suction blisters from patients with scleroderma and various skin disorders. (1986) (23)
Alefacept: a novel and selective biologic agent for the treatment of chronic plaque psoriasis. (2004) (23)
Melanocyte biology and melanogenesis: what's new? (2000) (23)
Determination of Melanin and Haemoglobin in the Skin of Idiopathic Cutaneous Hyperchromia of the Orbital region (ICHOR): A Study of Indian Patients (2012) (23)
Pathophysiology of psoriasis: science behind therapy. (2002) (23)
Linear IgA dermatosis and thyroid carcinoma. (1992) (22)
Efficacy of micronutrient supplementation on skin aging and seasonal variation: a randomized, placebo-controlled, double-blind study (2013) (22)
Effectiveness of cross polarized light and fluorescence diagnosis for detection of sub‐clinical and clinical actinic keratosis during imiquimod treatment (2010) (22)
Murine laminin alpha3A and alpha3B isoform chains are generated by usage of two promoters and alternative splicing. (1997) (22)
Altered expression of the hemidesmosome‐anchoring filament complex proteins in basal cell carcinoma: possible role in the origin of peritumoral lacunae (1997) (22)
A novel homozygous mutation affecting integrin alpha6 in a case of junctional epidermolysis bullosa with pyloric atresia detected in utero by ultrasound examination. (1998) (22)
Clinical and Cytological Effects of Pimecrolimus Cream 1% after Resolution of Active Atopic Dermatitis Lesions by Topical Corticosteroids: A Randomized Controlled Trial (2010) (22)
Stratum corneum pharmacokinetics of the anti-fungal drug, terbinafine, in a novel topical formulation, for single-dose application in dermatophytoses* (2007) (22)
Giant oral aphthous ulcers induced by nicorandil. (1998) (21)
[Psoriasis. Treatment]. (1999) (21)
Occurrence of Factor VIII‐related antigen positive cells in perivascular infiltrates of venous stasis dermatitis (1985) (21)
Objective assessment of topical corticosteroids and non‐steroidal anti‐inflammatory drugs in methyl‐nicotinate‐induced skin inflammation (1990) (21)
Ketanserin in the treatment of systemic sclerosis: a double‐blind controlled trial (1989) (21)
Association of eosinophilic fasciitis, multiple morphea and antiphospholipid antibody. (1994) (21)
Calcitriol ointment 3 microg/g is safe and effective over 52 weeks for the treatment of mild to moderate plaque psoriasis. (2009) (21)
Infectious and toxic cellulitis due to suicide attempt by subcutaneous injection of ricin (2004) (21)
A randomized, controlled study of the safety and efficacy of topical corticosteroid treatments of sunburn in healthy volunteers (2002) (21)
Rapid decay of alpha6 integrin caused by a mis-sense mutation in the propeller domain results in severe junctional epidermolysis bullosa with pyloric atresia. (2003) (21)
Signalling and chemosensitivity assays in melanoma: is mutated status a prerequisite for targeted therapy? (2011) (20)
Episodic erythema gyratum repens with ichthyosis and palmoplantar hyperkeratosis without signs of internal malignancy (1989) (20)
Diclofenac-Na Gel Is Effective in Reducing the Pain and Inflammation Associated with Exposure to Ultraviolet Light – Results of Two Clinical Studies (2005) (20)
Histopathological characterization of primary cutaneous melanoma using infrared microimaging: a proof‐of‐concept study (2010) (20)
The safety profile and sustained remission associated with response to multiple courses of intramuscular alefacept for treatment of chronic plaque psoriasis. (2010) (20)
Imiquimod 5% cream for external genital or perianal warts in human immunodeficiency virus‐positive patients treated with highly active antiretroviral therapy: an open‐label, noncomparative study (2009) (20)
Pathophysiology of Psoriasis: Science behind Therapy (2002) (20)
Effect of chronic sun exposure on human Langerhans cell densities. (1988) (20)
Nevoid hyperkeratosis of the nipple and areola mammae: ineffectiveness of etretinate therapy. (1986) (20)
The caspase‐cleaved form of LYN mediates a psoriasis‐like inflammatory syndrome in mice (2009) (20)
Absent expression of collagen XVII (BPAG2, BP180) in canine familial localized junctional epidermolysis bullosa. (1997) (20)
Safety and efficacy of combined use of 4-hydroxyanisole (mequinol) 2%/tretinoin 0.01% solution and sunscreen in solar lentigines. (2004) (19)
Executive Committee Report (1997) (19)
Vitiligo and depigmentation (1992) (19)
Reflectance confocal microscopy for recurrent lentigo maligna. (2011) (19)
[Ocular and cutaneous melanosis associated with the Sturge-Weber syndrome: clinical, histological, and ultrastructural studies of one case (author's transl)]. (1978) (19)
Giant melanin granules in vitiliginous achromia with malignant melanoma. (1978) (19)
[595 nm pulse dye laser therapy for viral warts: a single-blind randomized comparative study versus placebo]. (2007) (19)
[Pseudomonas aeruginosa in dermatology]. (1985) (18)
[Lyell syndrome or toxic epidermal necrolysis and Stevens-Johnson syndrome after treatment with fluoxetine]. (1992) (18)
[Treatment of scleroderma]. (1983) (18)
The rhino mouse model: the effects of topically applied all-trans retinoic acid and CD271 on the fine structure of the epidermis and utricle wall of pseudocomedones (2004) (18)
[Normal and abnormal skin color]. (2012) (18)
Hyper‐induction of skin ornithine decarboxylase activity in psoriatic patients (1986) (18)
Chronic urticaria: a comparison of management guidelines (2011) (18)
Secondary hyperpigmentation during interferon alfa treatment for chronic hepatitis C virus infection. (2013) (18)
Sequence of morphological events during topical application of retinoic acid on the rhino mouse skin (1991) (18)
Epidermolysis bullosa simplex with muscular dystrophy. (2010) (18)
Horny perifollicular mucinosis. An atypical pityriasis rubra pilaris-like eruption associated with HIV infection. (1993) (17)
Arthritis, Collagenous Colitis, and Discoid Lupus (1994) (17)
Pretibial epidermolysis bullosa. (1991) (17)
A noninvasive technique, reflectance confocal microscopy, for the characterization of melanocyte loss in untreated and treated vitiligo lesions. (2010) (16)
Involvement of the melanogenic enzymes expression (1994) (16)
[Understanding microcapillary angioma, observations in pregnant patients and in females treated with hormonal contraceptives]. (1989) (16)
Reduced Salivary Flow Induced by Systemic Isotretinoin May Lead to Dental Decay. A Prospective Clinical Study (2007) (16)
A pilot study using reflectance confocal microscopy (RCM) in the assessment of a novel formulation for the treatment of melasma. (2011) (16)
Primary localized gigantism and tuberous sclerosis. (1982) (16)
Congenital Ichthyosis in Two Cavalier King Charles Spaniel Littermates. (1994) (16)
A radiolabelled iodobenzamide for malignant melanoma staging (1994) (16)
Colorimetric assessment of the effects of azelaic acid on light-induced skin pigmentation. (1992) (16)
[Cutaneous localizations of chronic lymphoid leukemia in a zona area]. (1996) (15)
Mechanisms of Suntanning (2002) (15)
Expression of integrins in human nail matrix (1994) (15)
Myeloid metaplasia of the skin in two patients suffering from primary myelofibrosis. (1977) (15)
DNA conformation driven by AP‐1 triggers cell‐specific expression via a strong epithelial enhancer (2000) (14)
Safety aspects of topical methylprednisolone aceponate (MPA) treatment (1992) (14)
[Cheilitis granulomatosa in a child]. (2000) (14)
Disseminated pagetoid reticulosis associated with mycosis fungoides: immunomorphologic study. (1986) (14)
Efficacy and Safety of Efalizumab in Patients with Moderate-to-Severe Plaque Psoriasis Resistant to Previous Anti-Psoriatic Treatment: Results of a Multicentre, Open-label, Phase IIIb/IV Trial (2010) (14)
Junctional epidermolysis bullosa in two domestic shorthair kittens. (2005) (14)
[Cutaneous Waldenström's macroglobulinemia]. (2002) (13)
Hypomelanosis, immunity, central nervous system: No more “and”, not the end (2003) (13)
[Cutaneous manifestations of McCune-Albright syndrome: report of a case (author's transl)]. (1981) (13)
[Noninvoluting congenital hemangioma: 2 cases]. (2002) (13)
[Aseptic adenitis in pyoderma gangrenosum]. (1994) (13)
Dominant dystrophic epidermolysis bullosa associated with pyloric stenosis and congenital absence of skin. (2001) (13)
Graying of hair with age and sympathectomy. (1982) (13)
[Adult papular acrodermatitis (Gianotti's disease). Report of 3 cases]. (1977) (13)
[Alternaria tenuissima plurifocal cutaneous infection]. (1995) (13)
Neutrophilic dermatosis associated with chronic neutrophilic leukemia. (1993) (13)
Dermatomyositis-like syndrome in X-linked hypogammaglobulinemia. Case-report and review of the literature. (1990) (13)
Isolated deficient alpha6beta4 integrin expression in the gut associated with intractable diarrhea. (1999) (13)
[Cutaneous neuroendocrine carcinoma : apropos of a case]. (1983) (13)
Insulin receptors in cultured human keratinocytes (1984) (13)
Immunohistochemical Localization of Ornithine Decarboxylase in Human Skin (1987) (13)
The basement membrane protein BM-600/nicein codistributes with kalinin and the integrin alpha 6 beta 4 in human cultured keratinocytes. (1993) (13)
[Reactivation of bullous pemphigoid after influenza vaccination]. (1994) (13)
Focal Gaps in the Basement Membrane of Involved and Uninvolved Skin of Vitiligo: Are They Normal? (1994) (12)
Ofuji papuloerythroderma: a new European case. (1993) (12)
Atlas of Pigmentary Disorders (2016) (12)
Labial Melanotic Macule: A Potential Pitfall on Reflectance Confocal Microscopy (2012) (12)
Caspase 1/11 Deficiency or Pharmacological Inhibition Mitigates Psoriasis-Like Phenotype in Mice. (2019) (12)
[Optic neuropathy in Mediterranean boutonneuse fever]. (1988) (12)
Classification of Surgical Therapies for Vitiligo (2007) (11)
Identification of cysteinyldopa‐derived units in eumelanins from mammalian eyes (1981) (11)
Comparative treatment of extragenital lichen sclerosus with methylaminolevulinic Acid pulsed dye laser-mediated photodynamic therapy or pulsed dye laser alone. (2009) (11)
[Cutaneous malacoplakia associated with chronic hepatitis caused by hepatitis C virus]. (1993) (11)
[Cronkhite-Canada disease. Discussion apropos of a case and study of the pigmentation]. (1985) (11)
Familial rolled and spiral hairs with palmoplantar keratoderma. (1985) (11)
[Skin ageing and its prevention]. (2003) (11)
Vitiligo-like depigmentation and morpheas after specific intralymphatic immunotherapy for malignant melanoma. (1992) (11)
3% diclofenac in 2.5% hyaluronic acid (Solaraze) does not induce photosensitivity or phototoxicity alone or in combination with sunscreens. (2006) (11)
Malignant lymphoma and dermatitis herpetiformis. (1994) (11)
[Myiasis caused by Dermatoba hominis after an organized tours in Amazonia]. (1999) (10)
[Treatment of cellulite: effectiveness and sustained effect at 6 months with Endermologie demonstrated by several quantitative evaluation methods] (2004) (10)
Squamous cell carcinomas in Fanconi's anemia. (1981) (10)
[Association of lupus erythematosus and vitiligo (author's transl)]. (1981) (10)
Decreased circulating E rosette forming cells in psoralen UVA treated patients. (1977) (10)
Blue pseudochromhidrosis secondary to topiramate treatment. (2009) (10)
Morphological and molecular characterization of actinic lentigos reveals alterations of the dermal extracellular matrix (2017) (10)
Comparison of two different dose combinations of calcipotriol/hydrocortisone ointment used once daily for the treatment of psoriasis vulgaris on the face and body. (2010) (10)
Normal and abnormal skin color. (2012) (10)
[Pseudo-late onset cutaneous parphyria in haemodialysis patients. Clinical and histological features. 9 cases (author's transl)]. (1977) (10)
Polyamine levels in normal human skin (1983) (10)
[Psoriasis, metabolic syndrome and its components]. (2008) (10)
Leukoderma Acquisitum Centrifugum: Halo Nevus and Other Hypomelanoses Associated with Neoplasms (1983) (9)
Genetic Hypomelanoses: Acquired Depigmentation (2007) (9)
[Treatment of mycosis fungoides by 308 nm excimer laser: a clinical and histological study in 10 patients]. (2007) (9)
Cutaneous vasculitis with lesions mimicking degos' disease and revealing Crohn's disease. (1995) (9)
Urticarial vasculitis secondary to H1N1 vaccination. (2010) (9)
[Repigmentation of vitiligo induced by oral photochemotherapy. Histoenzymological and ultrastructural study (author's transl)]. (1978) (9)
Ulstrastructural study of leukodermic skin in Waardenburg-Klein syndrome. (1977) (9)
[Hypomelanosis of the skin and malignant melanoma (author's transl)]. (1978) (9)
[Mycobacterium fortuitum skin infection occurring after a facelift]. (2004) (9)
Cultured epithelia from junctional epidermolysis bullosa letalis keratinocytes express the main phenotypic characteristics of the disease (1990) (9)
Hyperpigmented acral papular mucinosis, systemic lupus erythematosus and universal alopecia. (1989) (8)
[Hallucinations during treatment with hydrochloroquine]. (2004) (8)
Special Features of Vitiligo (2008) (8)
Efficacy and Safety of the Betamethasone Valerate 0.1% Plaster in Mild-to-Moderate Chronic Plaque Psoriasis (2011) (8)
Minocycline induces an increase in the number of excreting pilosebaceous follicles in acne vulgaris. A randomised study. (1997) (8)
[Hypomelanosis of Ito: report of one case (author's transl)]. (1979) (8)
Chronic idiopathic urticaria for the generalist. (2003) (8)
A randomized controlled study to evaluate the depigmenting activity of l‐ascorbic acid plus phytic acid – serum vs. placebo on solar lentigines (2011) (8)
[Norwegian scabies: etiological grounds (author's transl)]. (1979) (8)
Uniform vascular response to different aetiological factors (1985) (8)
Efficacy and Safety of the Betamethasone Valerate 0.1% Plaster in Mild-to-Moderate Chronic Plaque Psoriasis A Randomized, Parallel-Group, Active-Controlled, Phase III Study (2011) (8)
Paraneoplastic pemphigus presenting as erosive lichen planus. (1998) (8)
Assignment of mouse nicein genes to Chromosomes 1 and 18 (1994) (8)
The skin as the possible reservoir for Candida albicans in the oculocutaneous candidiasis of heroin addicts. (1992) (7)
T and B lymphocytes in vitiligo (1978) (7)
Effect of tacrolimus on vitiligo in absence of UV radiation exposure. Authors' reply (2007) (7)
[Flutamide-induced late cutaneous pseudoporphyria]. (1999) (7)
Dyspigmentation of aged skin. (2001) (7)
[Vitiligo and cutaneous epitheliomas]. (1978) (7)
Localized depigmentation on genital melanosis: a clue for the understanding of vitiligo (2013) (7)
Sclerodermatous changes revealing porphyria cutanea tarda. (1994) (7)
Red scalp hair turning dark-brown at 50 years of age. (1986) (7)
Evaluation of the activity and safety of CS 21 barrier genital gel® compared to topical aciclovir and placebo in symptoms of genital herpes recurrences: a randomized clinical trial (2014) (7)
Public health issues arising from sale of illegal and potentially unsafe ‘tanning chemicals’ (2009) (7)
Oral photochemotherapy in lichen planus (LP) and mycosis fungoides (MF): ultrastructural modifications of the infiltrating cells. (1979) (7)
Confusions about color: formulating a more precise lexicon for pigmentation, pigmentary disorders, and abnormalities of "chromatics". (2006) (7)
Redefining clinical response in psoriasis: targeting the pathological basis of disease. (2004) (7)
[Physiology of cutaneous cicatrization]. (1994) (7)
Depigmentation of Hair and Mucous Membranes (2008) (7)
[Acute bacterial cellulitis]. (1987) (6)
Lamellar cells of sensory receptors and perineural cells of nerve endings of pig skin contain cytokeratins (2004) (6)
[Koebner phenomenon and multiple morphea]. (1998) (6)
[Oral photochemotherapy in atopic eczema]. (1979) (6)
Low-dose oral methotrexate induces apoptosis of tissue eosinophils in bullous pemphigoid. (2008) (6)
[Pyoderma gangrenosum, ovarian carcinoma treated with Melphalan and acute myelomonocytic leukaemia: report of one case and literature review (author's transl)]. (1979) (6)
Genetic Hypomelanoses: Generalized Hypopigmentation (2007) (6)
[Targetoid hemosiderotic hemangioma]. (1995) (6)
Cloning of laminin gamma2 cDNA and chromosome mapping of the genes for the dog adhesion ligand laminin 5. (2003) (6)
Scleroderma: ultrastructural study of the melanin pigmentary disturbances of the skin (1980) (6)
Photodamaged Skin: Clinical Signs, Causes and Management (1999) (6)
[Practical use of antiseptics in dermatology]. (1989) (6)
Cutaneous hypermelanosis and intramelanotic lipid droplets. (1980) (6)
Two cases of localized B-cell lymphoma in the acquired immunodeficiency syndrome. (1997) (6)
[Bullous pemphigoid following graft-versus-host reaction after bone marrow allograft]. (1988) (6)
[Biochemical and ultrastructural study of two familial cases of Winchester syndrome]. (1989) (6)
TherapeuTics for The clinician Calcitriol Ointment 3 μg / g Is Safe and Effective Over 52 Weeks for the Treatment of Mild to Moderate Plaque Psoriasis (2009) (6)
Psoriasis evaluation in clinical practice: systematic review and expert opinion (2010) (6)
[Efficacy of intravenous immunoglobulin in the treatment of scleromyxoedema]. (2010) (6)
[Cutaneous neuroendocrine carcinoma]. (1988) (6)
Evaluation of the efficacy and safety of a CS20® protective barrier gel containing OGT compared with topical aciclovir and placebo on functional and objective symptoms of labial herpes recurrences: a randomized clinical trial (2012) (5)
Reticulohistiocytomas versus multicentric reticulohistiocytosis. (1995) (5)
Affective disorders, light and melatonin. (1988) (5)
The tyrosinases of normal and diseased human skin (naevi, malignant melanoma, vitiligo). (1975) (5)
High protective effect of a broad-spectrum sunscreen against tetracycline phototoxicity. (2002) (5)
A model for studying the anti‐prostaglandin activity of drugs in human skin (1984) (5)
Hair color and alopecia areata. (1978) (5)
Melanins and Melanocytes (1995) (5)
[Auto-immune progesterone-induced dermatitis]. (1991) (5)
[Extracutaneous manifestations of neutrophilic dermatosis]. (1996) (5)
Papular eruption in AIDS: role of demodectic mites? (1994) (5)
[Pseudo-lupus erythema of the extremities in pathological pregnancies treated by salbutamol]. (1987) (5)
[Pustular vasculitis disclosing Behçet disease]. (1994) (5)
Induction of ornithine decarboxylase in psoriatic skin (1991) (5)
Approach to the Problem of Leukoderma (1983) (5)
[Clinical aspects and pathogenesis of UV-induced pigmentary disorders]. (2003) (5)
Skin Color and the Melanin Pigmentary System (1983) (5)
[Vitiligo with an inflammatory border. Apropos of 2 cases with review of the literature (18 cases)]. (1979) (5)
Impairement of thymus derived rosette forming cells during photochemotherapy (psoralen — U.V.A.) (1978) (5)
Comparison of UVA protection afforded by sunscreens with a high sun protection factor. (2002) (5)
[Oral photochemotherapy in vitiligo (author's transl)]. (1978) (5)
[Vertigo and hypokalemia. Two rare side effects of itraconazole]. (1994) (5)
[Paraneoplastic pemphigus: review of the literature, apropos of a case associated with chronic lymphoid leukemia]. (1995) (5)
PPAD: A tool for presumption of atopic dermatitis (2012) (5)
[Infections and skin diseases acquired in swimming pools]. (1991) (5)
Evaluation of the effect of Dardia® Lipo Line on skin inflammation induced by surfactants using the repeated open‐application test (2007) (5)
Genetic and Congenital Disorders (2020) (5)
Radiation myo-fasciitis. (2000) (5)
Lethal junctional epidermolysis bullosa with normal expression of BM 600 and antro-pyloric atresia: A new variant of junctional epidermolysis bullosa? (1992) (5)
Pathogenesis of Vitiligo (2007) (5)
[Aseptic meningitis during pyrazinamide therapy for lupus erythematosus]. (1993) (5)
[Clinical and statistical study of 100 patients with vitiligo. II. Associated lesions]. (1976) (5)
[Atypical clinical forms of bullous pemphigoid]. (1990) (4)
[Cutaneous pigmentation disorders in human immunodeficiency virus infection]. (1992) (4)
Severe sclerodermalike manifestations of the eosinophilia-myalgia syndrome despite concomitant colchicine therapy. (1991) (4)
[Severe erythema multiforme during terbinafine therapy]. (1995) (4)
[Staphylococcal nodular lymphangitis in a renal transplant recipient]. (2003) (4)
Chronic anal ulceration due to nicorandil (2004) (4)
Common antigen expression between human periderm and other tissues identified by GB1-monoclonal antibody (2004) (4)
["Gloves and socks" papular purpura associated with antiphospholipid antibodies]. (1993) (4)
[Erythema gyratum repens and primary bronchial cancer. Disappearance of the dermatosis under general corticoid therapy]. (1983) (4)
Hypomelanosis Secondary to Irradiation and Physical Trauma (1983) (4)
Lack of hypocomplementemia in chronic urticaria. (2000) (4)
Hyperpigmentation after bleomycin therapy (1978) (4)
[Treatment of vitiligo by association of DNCB-PUVA]. (1980) (4)
[Antiseptic treatment of the umbilical cord in newborns: survey and recommendations]. (1999) (4)
Papular acrodermatitis associated with hepatitis B virus infection. (1979) (4)
Anti‐inflammatory vs. inflammatory treatments for actinic keratoses (2003) (4)
Chronic varicella presenting as disseminated pinpoint-sized papules in a man infected with the human immunodeficiency virus. (1996) (4)
Bullous and pustular rheumatoid vasculitis: treatment by plasma exchange. (1983) (4)
[Dermal mastocytes, histaminaemia, and oral photochemotherapy (author's transl)]. (1980) (4)
[Comparative study of the activity of hyaluronic acid and dextranomer in the treatment of leg ulcers of venous origin]. (2001) (4)
[Psoriasis. Clinical cutaneous aspects]. (1999) (4)
Acquired féline hair shaft abnormality resembling trichorrhexis nodosa in humans. (1996) (4)
[Bacillary epithelioid angiomatosis in AIDS. Two cases]. (1992) (4)
Cholinesterases isoenzymes: a comparative study in the skin and plasma. (1979) (4)
Epidermolysis bullosa: Recent advances in understanding pathogenetic mechanisms (1992) (4)
What's new in hypochromy (2006) (4)
[Granuloma gluteale infantum: ultrastructural study (author's transl)]. (1980) (4)
[Antiphospholipid antibodies associated with cardiac myxoma simulating collagen vascular disease]. (1993) (3)
[Bupropion (Zyban) induced urticaria: 2 cases]. (2003) (3)
The safety of hydroquinone (2006) (3)
[Acquired ichthyosis during lipid-normalizing treatment]. (1986) (3)
[Alopecia areata and trisomy 21. About 2 cases (author's transl)]. (1978) (3)
Decreased circulating E rosette forming cells (1977) (3)
Seborrheic dermatitis and daylight. (1993) (3)
SP-04 Microphthalmia associated transcription factor (mitf) is a target of the pi3k pathway (2003) (3)
["Vanishing" finger pads syndrome: localized acquired cutis laxa?]. (1992) (3)
[Endemic subcutaneous Dirofilaria repens filariasis in Southern France]. (1998) (3)
Influence of Retinoic Acid on Epidermal Wound Healing in Man (1981) (3)
Unilateral nevoid telangiectasia. (1978) (3)
[Cutaneous leukocytoclastic vasculitis with circulating anticoagulant disclosing myxoma of the left atrium]. (1993) (3)
Desloratadine improves quality of life and measures of impaired sleep and daily activity in chronic idiopathic urticaria (2004) (3)
[The Waardenburg-Klein syndrome]. (1976) (3)
[Scleroderma en coup de sabre with homolateral chronic glaucoma (author's transl)]. (1977) (3)
Chronic bullous dermatosis of childhood. Immunological and ultrastructural studies on the melanocyte--dermal junction. (1978) (3)
Vitiligo, still an enigma! (1987) (3)
[Mucocutaneous lentiginosis, ephelides and cardiac myxoma]. (1988) (3)
Infliximab produces a sustained and significant improvement in psoriasis over 50 weeks of continuous therapy. (2005) (3)
Chromonychia following thermal injury. (1979) (3)
Milia during treatment of mycosis fungoides: follicular mycosis fungoides? (1994) (3)
[Oral photochemotherapy of psoriasis, clinical findings in 100 patients]. (1977) (3)
[Acrodermatitis enteropathica aspect caused by group B vitamin deficiency]. (1991) (3)
Relative potencies of several non‐steroidal anti‐inflammatory drugs against soya bean 15‐lipoxygenase (1983) (2)
Clinical Potential of Topical Corticosteroids (2012) (2)
α6β4 INTEGRIN DEFICIENCY. A NEW AETIOLOGY FOR PROTRACTED DIARRHOEA IN INFANCY (1997) (2)
Amelanotic changes in B 16 melanoma after transplantation to ‘Yellow’ Ay/a mice (2004) (2)
A More Precise Lexicon for Pigmentation, Pigmentary Disorders, and “Chromatic” Abnormalities (2007) (2)
[Pyoderma gangrenosum simulating erysipelas]. (2000) (2)
[Mycosis fungoides during B-cell lymphoma]. (1992) (2)
[Cryosurgery in the treatment of basal cell epithelioma of the eyelids]. (1989) (2)
Hypomelanosis Associated with Inflammation (1983) (2)
[Letter: Vitiligo, thymus defect and autoimmunity--a hypothetical pathogenesis]. (1975) (2)
Skin cleansing: an important problem in occupational dermatology. (1990) (2)
Comparative Study of the Keratin Polypeptide Profiles in Human and in Pig Hyperkeratotic Scabies (1986) (2)
[Assessment of the photosensitization potential of zinc gluconate]. (2005) (2)
Medical Treatment of Vitiligo (2007) (2)
[Focal epithelial hyperplasia. An unusual clinical aspect]. (1993) (2)
Desloratadine has a rapid and enduring impact on signs & symptoms in chronic idiopathic urticaria (2004) (2)
Cutaneous and urinary complications of central umbilical artery injection. (1978) (2)
[Chronic lymphoid leukemia in a case of systemic scleroderma]. (1991) (2)
Anonychia with Ectrodactyly of One Foot (1986) (2)
[Cutaneous neuroendocrine carcinoma with acquired immunodepression]. (1990) (2)
Epidermolysis bullosa acquisita with negative direct immunofluorescence. (1986) (2)
Connection of tacrolimus and 308nm excimer laser in treating vitiligo1 (2004) (2)
Use of conventional systemic treatments in psoriasis: systematic review and expert opinion of a panel of dermatologists (2011) (2)
Epidermolysis bullosa acquisita with negative direct immunofluorescence. (1985) (2)
Non-keratinocyte cells in hair follicles (with special emphasis to human hair follicles) (1989) (2)
Antioxidant supplementation and risk of skin cancers. (2008) (2)
[Photo-onycholysis induced by oral photochemotherapy]. (1978) (2)
Cholesterol crystal embolization presenting as erythema induratum of bazin. (1995) (2)
[Rothmund-Thomson syndrome. Apropos of a case]. (1985) (1)
[Normal and abnormal human skin color: from research to esthetics]. (2009) (1)
Xeroderma pigmentosum (2004) (1)
[Cutaneo-systemic amyloidosis disclosing a hyposecreting myeloma]. (1987) (1)
Expression of the antigen recognized by mAb GB36 in normal skin and in skin tumours (1995) (1)
[Cutaneous complications after sleep electroencephalography]. (1992) (1)
[Comparative study of normal and psoriatic skin using a micromethod for detection of enzymatic activity]. (1980) (1)
[Clinical trials in dermatology. Evaluation of the tolerability and efficacy of a topical antifungal agent in the treatment of superficial mycoses]. (1991) (1)
[Psoriasis: assessment of quality of life]. (2000) (1)
The propriety of sponsorship of dermatologic conferences. (2000) (1)
[Recurrent infectious and metastatic cellulitis cause by Escherichia coli]. (2000) (1)
Pigmentary disorders associated with sun exposure (1996) (1)
Hypomelanosis Associated with Endocrine Disorders (1983) (1)
Psoriasis ‐ pathogenesis (2010) (1)
ST005 Tazarotene: A new topical receptor-selective retinoid (1997) (1)
Chronic UVA exposure: protective effect on skin induced pigmentation by a daily use of a day care cream containing broad band sunscreen. (2002) (1)
[Renal manifestations of severe human aphthous diseases (author's transl)]. (1980) (1)
Évaluation du potentiel photosensibilisant du gluconate de zinc (2005) (1)
Changes in skin pigmentation in the elderly (1998) (1)
Response of epidermal polyamines to orally administered aromatic retinoid RO 10-9359 (2004) (1)
[Myalgia-hypereosinophilia syndrome caused by L-tryptophan]. (1990) (1)
Scanning electromicroscopy of suction blister-roofs from psoriatic lesions and normal skin. (1985) (1)
[Hepatitis and chickenpox: apropos of a case]. (1978) (1)
[Hepatotoxicity caused by dextropropoxyphene. Two cases, one of them with recurrence]. (1994) (1)
Combined Therapies for Vitiligo (2010) (1)
Fexofenadine hydrochloride: A new anti-H1 in the treatment of chronic idiopathic urticaria. Study comparing the efficacy and safety of four dosage regimes (1998) (1)
Detection of Novel LAMC 2 Mutations in Herlitz Junctional Epidermolysis Bullosa (2007) (1)
Melanocytes in pigmented macular amyloidosis of the skin (1981) (1)
[Idiopathic CD4 lymphocytopenia]. (1996) (1)
[Erythroderma disclosing transformation of refractory anemia with excess of blasts into lymphoblastic leukemia]. (1993) (1)
UVB Therapy for Pigmentary Disorders (2007) (1)
Vesiculobullous eruption associated with chronic lymphocytic leukemia: report of two cases. (1995) (1)
Acquired epidermolysis bullosa without basement membrane zone immunoreactants. (1986) (1)
[The 49 XXXXY syndrome. Report of a further case with leg ulcer and endocrine abnormalities (author's transl)]. (1980) (1)
["Bronze baby" syndrome]. (1994) (1)
[Efficacy of thalidomide against esophageal ulceration in HIV infection]. (1993) (1)
Rapid Publication Defective Expression of Plectin / HD 1 in Epidermolysis Bullosa Simplex with Muscular Dystrophy (2013) (1)
Pyemotes ventricosus Dermatitis (2008) (1)
[Pemphigus occurring in the course of treatment with D-penicillamine]. (1982) (1)
Granulome glutéal infantile (GGI): Etude ultrastructurale. (1980) (1)
[The dermo-epidermal junction and its acquired and hereditary pathology. A few recent advances]. (1992) (1)
Topical tacrolimus and pimecrolimus are not associated with skin atrophy: reply from author (2002) (1)
[Cutaneous symptoms of ulcero-haemorragic rectocolitis and of Crohn's disease (author's transl)]. (1978) (1)
Corrective gene transfer of keratinocytes obtained from patients with junctional epidermolysis bullosa (1998) (1)
[What's new in dermatological treatments?]. (2008) (1)
[Evaluation of the extravascular distribution of cefotiam (SCE 963) by the skin blister technic]. (1984) (1)
[The multiple lentigines syndrome and elastic dystrophy]. (1985) (1)
[Hazards of treatment of psoriasis with sulfasalozine]. (1992) (1)
[Vitiligo. Recent bibliographical data]. (1987) (1)
Vla and alpha 6 beta 4 integrin expression in neuroendocrine carcinomas of the skin (their xenografts on nude mice and a corresponding primary culture). (1996) (1)
[Oral photochemotherapy in the treatment of parapsoriasis guttata (author's transl)]. (1981) (1)
[Severe and resistant cutaneous involvement in dermatomyositis: value of intravenous immunoglobulins]. (1993) (1)
Vitiliginous achromia with malignant melanoma (1977) (1)
The 150 kDa chain of nicein/kalinin is a truncated isoform of laminin α1 chain distinct from the heavy chain of k-laminin (1994) (1)
Chapter-38 Importance of Pendulous Melanocytes in Melasma (2014) (0)
[Dysimmune adenopathies with eosinophilic myositis and fasciitis]. (1982) (0)
[Clinical trials in dermatology. The phase I trials]. (1991) (0)
[A case for diagnosis. Scalp gangrene due to temporal arteritis (Horton's disease)]. (1986) (0)
Increasing the knowledge in managing hyperpigmentary disorders: a report from the Pigmentary Disorders Academy (2006) (0)
Contents, Vol. 184, 1992 (1992) (0)
Prevention of solar-induced immunosuppression by a new highly protective broadspectrum sunscreen. (2002) (0)
Hypomelanoses Associated with Nutritional and Metabolic Disorders (1983) (0)
[Chronic edema, monoclonal dysglobulinemia and profuse telangiectasia: a distinct entity?]. (1997) (0)
[A method of detecting multiple enzymatic activities of various skin and melantin tissue extracts]. (1976) (0)
[Chronic furunculosis]. (1988) (0)
Dermo-epidermal distribution of ketoconazole in man. (1988) (0)
[Cutis marmorata congenita telangiectica with cutaneous elastic tissue anomalies. Clinical and histological findings in a 73-year-old patient]. (1977) (0)
PL003 Recent advances in the understanding of melanogenesis and melanin pigmentary disorders (1997) (0)
Evidence-Based Medicine Perspective (2010) (0)
Melanins and Melanocytes Form and Function (0)
Viewpoint 5 (2008) (0)
Diseases Affected by Heat (1994) (0)
Ultrastructural localization of nicein in normal human skin by low-temperature immunoelectron microscopy (1994) (0)
The anchoring filament protein kalinin is a laminin isotype (1992) (0)
Aminoisobutyric Acid Uptake in Normal and Transformed Human Epidermal Keratinocytes (1988) (0)
Prenatal diagnosis of junctional epidermolysis bullosa by aminiocentesis (1993) (0)
Abstract 4052: Highlighting intratumoral heterogeneity and peritumoral areas in human melanoma biopsies by infrared spectral microimaging (2012) (0)
SP-05 Differential Regulation of Egr-1 by HGF/SF in Melanocytes and Melanoma cells (2003) (0)
Studies of cicatricial pemphigoid autoantibodies reactivity on the immunodominant epitope of the BP180 ectodomain and nicein (1993) (0)
[Merkel's cell : current data]. (1983) (0)
[A case of yellow nails syndrome]. (1984) (0)
Gene polymorphisms of tumor necrosis factor !-308 and interleukin 10-1082 among asthmatic Egyptian children (2007) (0)
ILDS Newsletter No. 28 (2013) (0)
Interferon alpha 2A (Roferon) as an adjuvant therapy in melanoma stage I >1.5 mm: 290 (1993) (0)
Further evidence that impaired expression of LAMC2 gene is involved in Herlitz junctional epidermolysis bullosa (1994) (0)
[The Orf nodule]. (1983) (0)
Atopic dermatitis — Management through Europe: Geographical differences (1998) (0)
[Failure of cyclosporine in the treatment of psoriasis: role of lithium?]. (1995) (0)
Naevocellular naevus and psoriasis: histological and ultrastructural observations (1977) (0)
Chronic urticaria - why are patients dissatisfied with treatment? (2007) (0)
Erythema nodosum-like eruption in a patient with probable thorium-induced bone marrow failure. (1981) (0)
Vitiligo/nonsegmental Vitiligo Including Acrofacial and Universalis (2019) (0)
In vitro study of the cell populations in two cases of Kaposi's sarcoma (2004) (0)
Chapter-36 Update Scoring Methods and Non-invasive Measurement Methods in Melasma (Reliability Assessment and Validation of the Melasma Area and Severity Index and a New Modified MASI Scoring Method) (2014) (0)
Chemical and drug induced hypermelanoses. (1988) (0)
Connection of tacrolimus and 308nm excimer laser in treating vitiligo 1 1 Disclosure not available at press time. (2004) (0)
[Remicade in moderate to severe plaque psoriasis]. (2006) (0)
Comprar Designing and Implementing Global Selection Systems | James J. Nordlund | 9781405179928 | Wiley (2009) (0)
LAMC2 gene mutations associated with herlitz junctional epidermolysis bullosa in patients immunoreactive to laminin-5 and presenting mature hemidesmosomes (1998) (0)
The skin compartment of the 'melanocyte organ' may be altered in AIDS patients (1994) (0)
What's new in the understanding of vitiligo (1995) (0)
Workshop Vitiligo — Recent advancesWS073 The melanocyte reservoir in human skin (1997) (0)
[Cutaneous necrosis of the extremities during carbon monoxide poisoning]. (1995) (0)
[Value of pyrazinobutazone in the treatment of various inflammatory conditions]. (1972) (0)
Rab27a (2001) (0)
Pyloric Stenosis and Pyloric Atresia: The Same Pathogenesis? (2014) (0)
The tyrosinases of normal and deseased human skin (2004) (0)
[Detection of pseudo-porphyria cutanea tarda in 100 hemodialyzed patients (author's transl)]. (1977) (0)
[Primary sporotrichoid cutaneous nocardiosis caused by Nocardia asteroides. Review of the literature apropos of 2 cases]. (1987) (0)
[Cutaneous manifestations of infections in newborn infants]. (1990) (0)
[What are the objectives of moderate to severe psoriasis treatment?]. (2008) (0)
Contents, Vol. 194, 1997 (1997) (0)
Ultrastructural aspects of skin after cryoultramicrotomy. (1987) (0)
[Skin manifestations in renal transplants]. (1977) (0)
031 Ultrastructural relationship between laminin 5 (kalinin/nicein) and hemidesmosomes (1995) (0)
OnlineEarly Announcement (2004) (0)
Laser for Repigmenting Vitiligo (2007) (0)
Murine Laminin (cid:97) 3A and (cid:97) 3B Isoform Chains Are Generated by Usage of Two Promoters and Alternative Splicing* (1997) (0)
Ichthyosis nigricans: Ultrastructural study of the melanin pigmentary disturbances (1979) (0)
Reproduction of an abnormal basement membrane zone after terminal differentiation of a reconstructed epithelia with keratinocytes from junctional epidermolysis bullosa (1989) (0)
Evidence that human epidermal keratinocytes in culture transport amino-isobutyric acid (2004) (0)
[Macular and pigmented cutaneous amyloidosis]. (1974) (0)
The future of sunscreens. (2001) (0)
Progressive depigmentation of the coat of C3H mice after neonatal thymectomy. (1978) (0)
Functional analysis of laminin-5 demonstrates the pivotal role of the 440kDa extracellular form of the protein in cell adhesion (1998) (0)
[Surgical treatment of hypochromic macules in pheochromocytoma]. (1978) (0)
[Clinical trials in dermatology. Evaluation of the tolerability and efficacy of a topical antipsoriatic treatment]. (1991) (0)
Iconographies supplémentaires de l'article : A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: A randomized, double-blind, controlled trial (2013) (0)
Comprar Compression of Biomedical Images and Signals | Somesh Gupta | 9781848210288 | Wiley (2009) (0)
[Vesicular metastasis of malignant melanoma revealed by recurrent hepatic colic crises]. (1999) (0)
[Cutaneous and mucous hyperpigmentation in AIDS]. (1991) (0)
[Hermansky-Pudlak syndrome. Apropos of a case]. (1986) (0)
Pigmentation and Hypopigmentation: Vitiligo and Other Disorders (2011) (0)
S-Laminin gene (Lams) maps to F1 band of mouse Chromosome 9 (1994) (0)
Editorial (2000) (0)
The role of Malassezia yeast in seborrheic dermatitis (1998) (0)
WS110 New pigmentary disorders (1997) (0)
In Vitro and In Vivo Anti-Melanoma Effects of (2009) (0)
[Therapeutic management of plaque psoriasis: the interest of anti-TNFalpha]. (2005) (0)
[Melanoma: what is new?]. (1995) (0)
[Exploration using labelled bleomycin in dermatology. Its value and limits in the diagnosis of cutaneous epitheliomas, malignant melanomas and their metastasis]. (1974) (0)
Contents, Vol. 195, Supplement 1, 1997 (1997) (0)
High protective effect of UVA filter reinforced sunscreens against phototoxicity of chlorpromazine and benzoyl peroxyde (1998) (0)
Tyrosinase-negative albinism with congenital malformations and squamous cell carcinoma of the genitalia. (1982) (0)
Narrow-band TL-01 phototherapy or PUVA? That is the question! (2001) (0)
[Association of cardiac myxomas and pigmented cutaneous lesions: a new cardiocutaneous syndrome?]. (1986) (0)
[Polymerase chain reaction (PCR). A technology in full progress]. (1990) (0)
[Amniotic band syndrome]. (1997) (0)
[Subcutaneous cysticercosis]. (1996) (0)
Subject Index Vol. 194, 1997 (1997) (0)
[Trichophyton soudanense infection in two young girls]. (2005) (0)
[Rest room dermatitis during immunosuppression]. (1984) (0)
[Meningeal hemorrhage and Hermansky-Pudlak syndrome]. (1986) (0)
Executive Committee Report (1999) (0)
Chapter-37 Cutaneous Biophysical Characteristics of Melasma (2014) (0)
[Study of the action of a vascular protector on diabetic vascular fragility]. (1971) (0)
Modification of a Device and Its Application for Intralesional Cryosurgery of Old Recalcitrant Keloids (2016) (0)
[Clinical trials in dermatology. Statistical support]. (1991) (0)
A new subset of junctional epidermolysis bullosa is characterized by the absence of immunoreactivity of the anchoring filament protein ladinin-1. (1996) (0)
[Wound healing]. (1983) (0)
Infectious and Parasitic Hypomelanosis (1983) (0)
[Biomaterials and dressings]. (1988) (0)
73rd Annual Meeting of the Swiss Society for Dermatology and Venerology (1992) (0)
Aids, Hypermelanosis, melasma and α‐MSH (1996) (0)
Contents, Vol. 174, 1987 (1987) (0)
aMSH stimulates MAP kinases in B16 melanoma cells (1994) (0)
Are melanins photoprotective (1996) (0)
Early expression of laminin-5 in wound healing of human skin transplanted onto the nude mouse (1998) (0)
Forskolin inhibits undifferentiate melanocyte and B16 cells migration on gold particles. (1996) (0)
Leukodermas without Hypomelanosis (1983) (0)
[Clinical trials in dermatology. Evaluation of the tolerability and efficacy of a topical anti-acne]. (1991) (0)
Immunohistochemical characterization of the human nail matrix in vivo (1993) (0)
Acknowledgement to Referees for Dermatology 2004 (2004) (0)
[Value of pyrazinobutazone in the treatment of different inflammatory states]. (1972) (0)
[Biotherapies for psoriasis: Options following the suspension of Raptiva?]. (2009) (0)
Dermal Mastocytes, Histaminemia, and Opal Photochemotherapy (1981) (0)
[Hepatic cutaneous porphyria associated with chronic lymphoid leukemia]. (1972) (0)
S058 The ozone depletion and the skin (1997) (0)
[Oculocutaneous albinism]. (1992) (0)
[Gene therapy for hereditary bullous epidermolysis]. (2000) (0)
Transforming growth factor-beta stimulates laminin α3A gene expression through cooperation between AP-1 binding sites (1998) (0)
[Clinical and statistical study of 100 vitiligo patients. I. Etiologic factors and clinical study]. (1976) (0)
Newsletter No. 17 (2011) (0)
[Normal and abnormal human skin colour: from research to aesthetics]. (2008) (0)
[Relationship between skin hyperpigmentation in AIDS and serum alpha-Melanocyte Stimulating Hormone level]. (1992) (0)
Disseminated pustulosis revealing bowel by-pass syndrome without by-pass (1993) (0)
[A case of retroperitoneal fibrosis associated with gangrene of the external genitalia in a diabetic patient]. (1971) (0)
[Eosinophilia-myalgia syndrome after ingestion of L-tryptophan]. (1990) (0)
Melanoma in a Patient With Parkinson Disease (2016) (0)
[Daivobet: new therapeutic management for psoriasis. Introduction]. (2004) (0)
[Depigmenting chemical agents]. (1986) (0)
[Clinical trials in dermatology. Evaluation of the tolerability and efficacy of a topical anti-inflammatory treatment in atopic dermatitis]. (1991) (0)
Contents Vol. 209, 2004 (2004) (0)
Identification of a novel homozygous nonsense mutation in the LAM C2 gene in a family affected by herlitz junctional epidermolysis bullosa (1994) (0)
[Flora of the skin]. (1987) (0)
ILDS Newsletter No. 24 (2012) (0)
[Fibronectin level in dermal suction fluid in systemic scleroderma]. (1984) (0)
Healing of Pure Epidermal Wounds in Man: A Quantitative Study (1987) (0)
Newsletter ILDS No. 14 (2010) (0)
Antioxidant supplementation and risk of skin cancers (Letter) (2008) (0)
Subject Index Vol. 209, 2004 (2004) (0)

This paper list is powered by the following services:

Jean‐paul Ortonne's Academic­Influence.com Rankings

Jean‐paul Ortonne's Degrees

Why Is Jean‐paul Ortonne Influential?

Jean‐paul Ortonne's Published Works

Published Works

Jean‐paul Ortonne's AcademicInfluence.com Rankings